Journals / Journal of Clinical and Analytical Medicine / 2013 / Cilt: 4 - Sayı: 5

Geç tanı konulan subklinik von-willebrand hastalığı olgu sunumu

Delayed diagnosed subclinical von willebrand disease case report

Pages
415–417
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a result, seen at the rate of 1% in community screening and the most common inherited bleeding diathesis, in the cases of Von Willebrand disease’s subclinical a good patient history should be taken in order to be able to be early dianosed diagnosed and to be able to be prevent the complications and also the necessary tests for diagnosis should be performed.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The evaluation of the patients who will be operated in terms of preoperative bleeding diathesis is an obligation.
📊
Key Findings & Data:This evaluation contains history, physical examination and tests of haemostasis.
💡
Conclusion & Impact:As a result, seen at the rate of 1% in community screening and the most common inherited bleeding diathesis, in the cases of Von Willebrand disease’s subclinical a good patient history should be taken in order to be able to be early dianosed diagnosed and to be able to be prevent the complications and also the necessary tests for diagnosis should be performed.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The evaluation of the patients who will be operated in terms of preoperative bleeding diathesis is an obligation. This evaluation contains history, physical examination and tests of haemostasis. That are as a routin used among these tests are the number of platelet, PT, aPTT and the values of INR. Despite these assessments, all of the bleeding-clotting disorders have not been able to be determined. Therefore, due to omitted diagnosis of bleeding diathesis, in orthopedic proce- dures, hemartroz hemarthrosis, intramuscular hematoma, and abandoned bleed- ing may develop in the postoperative period. These complications are the causes of morbidity and mortality. In one of our cases, who had osteochondroma in his femur diaphysis and also whose preoperative history, examination and mentioned tests were normal, developed recurrent bleeding and hematoma in the operative area in the postoperative period. Von Willebrand disease was determined in the examination which was carried out by being considered bleeding diathesis. As a result, seen at the rate of 1% in community screening and the most common inherited bleeding diathesis, in the cases of Von Willebrand disease’s subclinical a good patient history should be taken in order to be able to be early dianosed diagnosed and to be able to be prevent the complications and also the necessary tests for diagnosis should be performed.

Özet

Opere edilecek hastaların preoperatif kanama diyatezi açısından değerlendirilmesi bir zorunluluktur. Bu değerlendirme; anamnez, fizik muayene ve hemostaztestlerini içermektedir. Bu testler arasında rutin olarak kullanılanlar; platelet sayısı, protrombin zamanı, aktive parsiyel tromboplastin zamanı ve INR değerleridir. Bu değerlendirmelere rağmen kanama-pıhtılaşma bozukluklarının tamamı tespit edilememektedir. Bu nedenle tanısı atlanmış kanama diyatezi sebebiyle ortopedik girişimlerde postoperatif dönemde hemartroz, kas içi hematom ve abondan ka- namalar gelişebilir. Bu komplikasyonlar morbidite ve mortalite sebepleridir. Femurdiafizinde osteokondromu bulunan ayrıca preoperatif anamnezi, fizik muayenesive belirtilen hemostaz testleri doğal olan bir olgumuzda, postoperatif dönemdecerrahi sahada tekrarlayan kanama ve hematom gelişti. Kanama diyatezi düşünü-lerek yapılan incelemede von Willebrand hastalığı saptandı. Sonuç olarak, toplumtaramasında % 1 oranında görülen, en sık kalıtsal kanama diatezi olan von Willebrand hastalığının subklinik olgularında erken tanı konabilmesi ve komplikasyonların önlenebilmesi için iyi bir hasta anamnezi alınmalı ayrıca tanıya yönelik gerekli testler yapılmalıdır.

🔖

Cite This Article

GÖKTAŞ, U., TÜRKTAŞ, U., DEMİR, C., CEYLAN, M. F., GÜNER, S. (2022). Geç tanı konulan subklinik von-willebrand hastalığı olgu sunumu. Journal of Clinical and Analytical Medicine, Cilt: 4 - Sayı: 5, 415–417. https://ajindex.com/articles/561600

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Francis CW, Kaplan KL. Hematologic problems in the surgical patient: Bleed- ing and thrombosis. In Hematology Basic Principles and Practice. Eds: Hoffman R, Benz EJ, Shattil SJ, Furie B, Cohen HJ, Silberstein LE, McGlave P. Vol 1. 3rd ed. Edinburgh: Churchill Livingstone; 2000, p. 2381–2391
  2. Cobas M. Preoperative assessment of coagulation disorders. Int Anesthesiol Clin 2001; 39(2):1–15
  3. Rapaport SI. Preoperative hemostatic evaluation: which tests, if any? Blood 1983;61(2): 229–231
  4. Asaf T, Reuveni H, Yermiahu T, Leiberman A, Gurman G, Porat A at al. The need for routine pre-operative coagulation screening tests (prothrombin time pt/partial thromboplastin time ptt) for healthy children undergoing elective tonsillectomy and/or adenoidectomy. International Journal Of Pediatric Otorhinolaryngology 2001;61(3):217-222
  5. Owen CA. Historical account of tests of hemostasis. Am J Clin Pathol. 1990;93(1):3-8
  6. Gill JC: Diagnosis and treatment of von Willebrand disease. Hematol Oncol Clin North Amer. 2004;18(3):1277-82
  7. Rodeghiero F, Castaman G, Dini E. Epidemıological investigation of the prevalence of von Willebrand’s disease. Blood 1987;69(2):454-58
  8. Gürsel T, Bumin Ç, Ç Özaltın S. Von Willebrand hastalığının prevalansı. Doğa- Turk J Med Sci,1992;16(3):324-25
  9. Romani T, Mourik JA. Biosynthesis, processing and secretion of von Willebrand factor: biological implications. Best Practice and Research - Clinical Haematology. 2001;14(2):240-42
  10. Italian Working Group. Spectrum of von Willebrand disease Br.J.Haematol 1977;35(1):101-04
  11. Ginsburg D. Von Willebrand Disease. In, William’s Hematology. Eds: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U. Vol 1. 3rd ed. New York: McGraw Hill; 2001, p. 1813–28.